CARDIOVASCULAR JOURNAL OF AFRICA • Volume 33, No 2, March/April 2022 58 AFRICA 11. Onyemelukwe G, Stafford WJT. Serum lipids in Nigerians: the effect of diabetes mellitus. Trop Geogr Med 1981; 33(4): 323–328. 12. Kesteloot H, Oviasu V, Obasohan A, Olomu A, Cobbaert C, Lissens WJA. Serum lipid and apolipoprotein levels in a Nigerian population sample. Atherosclerosis 1989; 78(1): 33–38. 13. Oguejiofor OC, Onwukwe CH, Odenigbo CU. Dyslipidemia in Nigeria: prevalence and pattern. Ann Afr Med 2012; 11(4): 197–202. 14. Nwakile PC, Chori BS, Danladi B, Umar A, Okoye IC, Nwegbu M, et al. Removing the mask on hypertension (REMAH) study: Design; quality of blood pressure phenotypes and characteristics of the first 490 participants. Blood Press 2019: 1–10. 15. Odili AN, Danladi B, Nwakile PC, Okoye I, Abdullahi U, Nwegbu MM, et al. Prevalence, awareness, treatment and control of hypertension in Nigeria: Data from a nationwide survey 2017. Glob Heart 2020; 15(1). 16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499–502. 17. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20(4): 470–475. 18. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 1995; 41(5): 717–723. 19. Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry J, Esders TW, et al. Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem 1978; 24(8): 1343–1350. 20. World Health Organisation. Cardiovascular disease risk factors: new areas for research. Report of a WHO scientific group, Geneva, 1994. 21. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31(7): 1281–1357. 22. Akinkugbe OO. Non-communicable diseases in Nigeria. Final report of a national survey: Federal Ministry of Health and Social Services, 1997. 23. Sani MU, Wahab KW, Yusuf BO, Gbadamosi M, Johnson OV, Gbadamosi A. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population – a cross sectional study. BMC Res Notes 2010; 3: 11. 24. Gebreyes YF, Goshu DY, Geletew TK, Argefa TG, Zemedu TG, Lemu KA, et al. Prevalence of high blood pressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015. PloS One 2018; 13(5): e0194819. 25. Asiki G, Murphy GA, Baisley K, Nsubuga RN, Karabarinde A, Newton R, et al. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey. PloS One 2015; 10(5): e0126166. 26. Oladapo O, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AJC. A prevalence of cardiometabolic risk factors among a rural Yoruba southwestern Nigerian population: a population-based survey. Cardiovasc J Afr 2010; 21(1): 26–31. 27. Akpa M, Agomouh D, Alasia DJN. Lipid profile of healthy adult Nigerians in Port Harcourt, Nigeria. Niger J Med 2006; 15(2): 137–140. 28. Sabir AA, Isezuo SA, Ohwovoriole AE, Fasanmade OA, Abubakar SA, Iwuala S, et al. Rural–urban difference in plasma lipid levels and prevalence of dyslipidemia in Hausa-Fulani of north-western Nigeria. Ethn Dis 2013; 23(3): 374–378. 29. Aliyu AA, Amadu L. Urbanization, cities, and health: the challenges to Nigeria – A review. Ann Afr Med 2017; 16(4): 149–158. 30. Urbanization from 2009 to 2019. 2020. Available from: https://www. statista.com/statistics/455904/urbanization-in-nigeria/. 31. Barrett CB, Reardon T, Webb P. Nonfarm income diversification and household livelihood strategies in rural Africa: concepts, dynamics, and policy implications. Food Policy 2001; 26(4): 315–331. 32. Opoku S, Gan Y, Fu W, Chen D, Addo-Yobo E, Trofimovitch D, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC Public Health 2019; 19(1): 1500. 33. Gao N, Yu Y, Zhang B, Yuan Z, Zhang H, Song Y, et al. Dyslipidemia in rural areas of North China: prevalence, characteristics, and predictive value. Lipids Health Dis 2016; 15(1): 154. 34. Akinboboye O, Idris O, Akinboboye O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens 2003; 17(6): 381–387. 35. Muna WF. Cardiovascular disorders in Africa. World health statistics quarterly Rapport trimestriel de statistiques sanitaires mondiales. World Health Stat Q 1993; 46(2): 125–133. 36. Oyebode O, Pape UJ, Laverty AA, Lee JT, Bhan N, Millett CJ. Rural, urban and migrant differences in non-communicable disease risk-factors in middle income countries: a cross-sectional study of WHO-SAGE data. PloS One 2015; 10(4): e0122747. 37. Djoussé L, Arnett DK, Coon H, Province MA, Moore LL, Ellison RC. Fruit and vegetable consumption and LDL cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2004; 79(2): 213–217. 38. Takahashi MM, de Oliveira EP, Moreto F, Portero-McLellan KC, Burini RC. Association of dyslipidemia with intakes of fruit and vegetables and the body fat content of adults clinically selected for a lifestyle modification program. Arch Latinoam Nutr 2010; 60(2): 148–154. 39. Dean WR, Sharkey JR. Rural and urban differences in the associations between characteristics of the community food environment and fruit and vegetable intake. J Nutr Educ Behav 2011; 43(6): 426–433. 40. Ruel MT, Minot N, Smith L. Patterns and determinants of fruit and vegetable consumption in sub-Saharan Africa: a multicountry comparison: WHO Geneva; 2005. 41. Miller V, Yusuf S, Chow CK, Dehghan M, Corsi DJ, Lock K, et al. Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Glob Health 2016; 4(10): e695–e703. 42. Qi L, Ding X, Tang W, Li Q, Mao D, Wang Y. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. Int J Environ Res Public Health 2015; 12(10): 13455–13465. 43. Reddy Kilim S, Chandala SR. A comparative study of lipid profile and oestradiol in pre- and post-menopausal women. J Clin Diagn Res 2013; 7(8): 1596–1598. 44. Newnham HH. Oestrogens and atherosclerotic vascular disease – lipid factors. Bailliere’s clinical endocrinology and metabolism. Bailliere’s Clin Endocrinol Metab 1993; 7(1): 61–93. 45. Sun GZ, Li Z, Guo L, Zhou Y, Yang HM, Sun YX. High prevalence of dyslipidemia and associated risk factors among rural Chinese adults. Lipids Health Dis 2014; 13: 189. 46. Sial S, Coggan AR, Carroll R, Goodwin J, Klein S. Fat and carbohydrate metabolism during exercise in elderly and young subjects. Am J Physiol 1996; 271(6 Pt 1): E983–989. 47. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994; 93(6): 2438–2446.
RkJQdWJsaXNoZXIy NDIzNzc=